Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Monopar Therapeutics (MNPR)

Monopar Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MNPR
DateTimeSourceHeadlineSymbolCompany
07/02/202522:01Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:MNPRMonopar Therapeutics Inc
28/01/202505:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MNPRMonopar Therapeutics Inc
27/01/202522:19Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MNPRMonopar Therapeutics Inc
23/01/202518:10PR Newswire (US)Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar TherapeuticsNASDAQ:MNPRMonopar Therapeutics Inc
15/01/202522:01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MNPRMonopar Therapeutics Inc
02/01/202523:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNPRMonopar Therapeutics Inc
02/01/202523:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNPRMonopar Therapeutics Inc
23/12/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
23/12/202411:01Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MNPRMonopar Therapeutics Inc
20/12/202414:00GlobeNewswire Inc.Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded WarrantsNASDAQ:MNPRMonopar Therapeutics Inc
18/12/202422:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MNPRMonopar Therapeutics Inc
18/12/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MNPRMonopar Therapeutics Inc
17/12/202422:01Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:MNPRMonopar Therapeutics Inc
17/12/202421:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNPRMonopar Therapeutics Inc
06/12/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
05/12/202421:21GlobeNewswire Inc.Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-LuNASDAQ:MNPRMonopar Therapeutics Inc
03/12/202413:00GlobeNewswire Inc.Monopar to Present at the 36th Annual Piper Sandler Healthcare ConferenceNASDAQ:MNPRMonopar Therapeutics Inc
29/11/202422:01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MNPRMonopar Therapeutics Inc
08/11/202413:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
08/11/202413:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MNPRMonopar Therapeutics Inc
08/11/202413:00GlobeNewswire Inc.Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent DevelopmentsNASDAQ:MNPRMonopar Therapeutics Inc
30/10/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
30/10/202417:42GlobeNewswire Inc.Monopar Therapeutics Inc. Announces Closing of $19.2 Million Public Offering of Common StockNASDAQ:MNPRMonopar Therapeutics Inc
29/10/202420:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MNPRMonopar Therapeutics Inc
29/10/202401:15GlobeNewswire Inc.Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common StockNASDAQ:MNPRMonopar Therapeutics Inc
28/10/202420:04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MNPRMonopar Therapeutics Inc
28/10/202420:00GlobeNewswire Inc.Monopar Therapeutics Inc. Announces Proposed Public Offering of Common StockNASDAQ:MNPRMonopar Therapeutics Inc
24/10/202411:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
24/10/202411:00GlobeNewswire Inc.Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug CandidateNASDAQ:MNPRMonopar Therapeutics Inc
22/10/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MNPR